Table 3.

Research Questions Developed Through Small-Group Breakout Session Discussions That Aim to Address Key Concerns Highlighted as Guiding Themes

ART education, safety, and adherence

1. What are the drivers of non-adherence? Is it true non-adherence, or are they seeking health care elsewhere?

2. What can we do to promote adherence? How can we increase disclosure of non-adherence?

Understanding the health risks for children who are HEU

1. What components of the HEU phenotype are associated ART exposure (mom vs infant)?

2. How does ongoing HIV viral replication alter the HEU phenotype? Will switching to new therapies effect the HEU phenotype?

3. What is the weight of the various risk factors that are contributing?

4. When do different types of neurodevelopmental dysfunctions emerge?

Breastfeeding practices and food/nutrition security

1. Is there a difference in infant outcomes associated with mixed vs exclusive breastfeeding?

2. Does food security impact BF practices?

3. How does nutrition security affect BM composition and infant growth?

4. How can we increase length of BF? What prevents mothers from meeting the guidelines?

Abbreviations: ART, antiretroviral therapy; HEU, HIV-exposed, uninfected; BF, Breastfeeding; BM, Breastmilk.